Product Images Pirfenidone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Pirfenidone NDC 42571-335 by Micro Labs Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pirfenidone-267mg-lbl.jpg - pirfenidone 267mg lbl

pirfenidone-267mg-lbl.jpg - pirfenidone 267mg lbl

Each tablet of this medication contains 267 mg of pirfenidone, and the NDC number is 42571-335-90. The usual dosage and administration information can be found in the package insert. The medication should be stored at a temperature of 25°C (77°F) with excursions allowed between 15° to 30°C (59° to 86°F) in accordance with USP Controlled Room Temperature guidelines. The medication is for prescription use only and should be kept out of reach of children. This medication is manufactured for Micro Labs USA, Inc. with a production date of rev.02/2022.*

pirfenidone-801mg-lbl.jpg - pirfenidone 801mg lbl

pirfenidone-801mg-lbl.jpg - pirfenidone 801mg lbl

This is a description of a medication containing pirfenidone with a dosage of 801mg per tablet. The directions for the dosage and administration information can be found on the package insert. The tablets should be stored between 15° to 30°C (59° to 86°F). The medication is manufactured by Micro Labs USA, Inc. and comes in a bottle of 90 tablets. This medication is only available through a prescription and should be kept out of reach of children. The text does not provide complete information about the medicine's purpose or indications.*

figure 1 - pirfenidone figure1

figure 1 - pirfenidone figure1

This appears to be a table showing the percentage of patients experiencing worsening or improving lung function (measured by FVC or forced vital capacity) after taking either pirfenidone or a placebo over a period of 52 weeks. The numbers in parentheses seem to indicate the number of patients in each group. More information is needed to fully understand the context and purpose of this table.*

figure 2 - pirfenidone figure2

figure 2 - pirfenidone figure2

figure 3 - pirfenidone figure3

figure 3 - pirfenidone figure3

Structure - pirfenidone structure

Structure - pirfenidone structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.